Eli Lilly Q4 Earnings: Strong Demand For Mounjaro But Prices Dip, Forecasts Over 30% Jump In 2025 Sales On Newer Medicines
On Thursday, Eli Lilly and Co (NYSE:LLY) stock is trading higher after the company released better-than-expected fourth-quarter earnings and provided 2025 guidance.
The U.S. pharma giant reported fourth-quarter revenue of $13.53 billion, up 45% year over year, almost in line with the consensus of $13.57 billion.
The increase was driven by a 48% increase in volume, partially offset by a 4% decrease due to lower realized prices.
The volume increase was driven by growth from Mounjaro and Zepbound. Lower realized prices were primarily driven by Mounjaro, partially offset by Zepbound and Humalog.
New Products revenue grew by $3.15 billion to $5.64 billion in Q4 2024, led by Zepbound and Mounjaro. Growth Products revenue increased 13% to $5.95 billion, driven by growth in Verzenio and Jardiance, partially offset by lower Trulicity sales.
Also Read:
The company reported an adjusted EPS of $5.32, compared to $2.49 from a year ago, beating the consensus of $4.94.
Mounjaro sales jumped 60% to $3.53 billion. Sales of Verzenio (a breast cancer drug) increased 36% to $1.56 billion, and sales of diabetes drug Jardiance increased 50% to $1.19 billion.
Zepbound sales reached $1.91 billion, up from $175.8 million a year ago. Trulicity sales fell 25% to $1.25 billion.
Guidance: Eli Lilly forecasts fiscal year 2025 sales of $58 billion-$61 billion versus a consensus of $59.91 billion and $45.04 billion in 2024.
The company adds that the midpoint represents approximately 32% growth compared to 2024, driven by new Lilly medicines such as Zepbound, Mounjaro, Jaypirca, Ebglyss, Omvoh and Kisunla; approvals of new indications for existing Lilly medicines; launches of Mounjaro in additional worldwide markets; and potential launches of new medicines such as imlunestrant for metastatic breast cancer.
The company continues to invest heavily in increasing manufacturing capacity and estimates producing at least 1.6 times the amount of salable incretin doses in the first half of 2025 compared to the first half of 2024.
Eli Lilly forecasts 2025 adjusted EPS of $22.50-$24.00 compared to $12.99 in 2024 and the consensus of $22.69.
Price Action: At last check on Thursday, LLY stock was up 1.11% at 851.49 during the premarket session.
Read Next:Photo by Ciara Kimsey via Shutterstock
Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market.
Get the latest stock analysis from Benzinga?
ELI LILLY (LLY): Free Stock Analysis Report
This article Eli Lilly Q4 Earnings: Strong Demand For Mounjaro But Prices Dip, Forecasts Over 30% Jump In 2025 Sales On Newer Medicines originally appeared on Benzinga.com
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Oklo Rallies on Seaport Buy Upgrade
Oklo (NYSE:OKLO) jumps 4.8% after Seaport Global upgraded the nuclear tech developer to Buy, citing strong project milestones and leadership enhancements. Seaport's Jeff Campbell set a $71 price target, arguing that Oklo's progress at the Idaho National Laboratory site and new CTO hire Pat Schweiger make it a standout in advanced nuclear. Warning! GuruFocus has detected 2 Warning Sign with OKLO. Oklo has wrapped up its drilling campaign at INL with a memorandum of agreement and an interface agreement with the Department of Energy, while also kicking off the NRC's Phase 1 combined license pre-application readiness assessment. The company has submitted a licensed operator topical report and is gearing up to file its licensing project plan for the Oklo Fuel Foundry, signaling management's confidence in regulatory momentum. Campbell flagged fuel availability as the key variable driving Oklo's upside, and noted the firm's eligibility for Defense Innovation Unit awards under the Advanced Nuclear Power for Installations programproof that Oklo has cleared technical gates and is vying to deploy its 15 MW Aurora microreactor at military bases. The upgrade comes after OKLO's stock surged 148% year-to-date, suggesting that fresh Buy-side conviction could fuel a second wave of gains. Why It Matters: As nuclear microreactors gain traction for remote power and defense use cases, Oklo's regulatory headway and DoE partnerships position it to capitalize on a growing demand for clean, resilient energy. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Warren Buffett Recently "Came Pretty Close" to Spending $10 Billion On an Acquisition, and I Strongly Believe One of These 2 Companies Was the Target
During Berkshire Hathaway's annual shareholder meeting. Warren Buffett noted that he and his team nearly pulled the trigger on a $10 billion deal. One potential buyout target is a legal monopoly that Buffett's company already holds a 35% stake in. Meanwhile, the other possible acquisition target is a time-tested business that has the second longest consecutive annual dividend streak of any U.S. public company. 10 stocks we like better than Sirius XM › There's not a billionaire investor on Wall Street who captivates the attention of professional and everyday investors like Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett. He earned his nickname, the "Oracle of Omaha," by absolutely crushing the broad-based S&P 500 in the return column over the last 60 years. No event is more special than Berkshire Hathaway's annual shareholder meeting, which typically draws in the neighborhood of 40,000 people. This meeting features a question-and-answer (Q&A) session that extends hours and allows investors to pick the brain of one of Wall Street's most successful asset managers. While the headline takeaway of Berkshire Hathaway's latest annual meeting is that the 94-year-old Buffett will be stepping aside as CEO by the end of the year and handing the reins to predetermined successor Greg Abel, this was far from the only meaningful announcement. Berkshire's chief also mentioned during the Q&A session that he and his team nearly pulled the trigger on a sizable acquisition. Said Buffett: "We came pretty close to spending $10 billion, not that long ago, for example, but we'd spend $100 billion. I mean, those decisions are not tough to make when something is offered that makes sense to us and that we understand and offers good value." With Buffett being a net seller of stocks for 10 consecutive quarters and growing Berkshire Hathaway's cash pile to almost $348 billion amid a historically pricey stock market, "good value" has been tough to come by. Although Warren Buffett, ultimately, didn't pull the trigger on this teased $10 billion deal, there are two companies -- one of which is a legal monopoly -- which perfectly fit the bill as potential targets of a $10 billion acquisition. If there's one stock that makes for a logical acquisition target for Warren Buffett's company at a $10 billion price tag, its satellite-radio operator Sirius XM Holdings (NASDAQ: SIRI). Sirius XM has a market cap of nearly $7.4 billion. There are a couple of variables that make Sirius XM a potentially logical buyout target for Berkshire Hathaway. To begin with, Berkshire is its largest shareholder. As of the end of March, Buffett's company held 35.4% of Sirius XM's outstanding shares. Completing the purchase of the remaining shares at a premium price still wouldn't cost Berkshire $10 billion out of pocket. Secondly, Sirius XM provides a sustainable competitive advantage, which is something that Warren Buffett tends to seek out in the businesses he invests in. Although it's still competing for listeners with traditional radio providers, it's the only company with a satellite-radio license. Being a legal monopoly should afford Sirius XM a level of subscription pricing power that other companies can't match. The third factor that would have made Sirius XM an ideal $10 billion acquisition target for Buffett is its diversified revenue stream. Whereas terrestrial and online radio providers almost exclusively generate their revenue from advertising, Sirius XM brings in a little north of three-quarters of its net sales from subscriptions. The value of Sirius XM's approach is that its cash flow remains more predictable and consistent during inevitable economic downturns where ad spending can quickly dry up. It's also worth mentioning that Buffett has previously demonstrated a willingness to establish large investment holdings in media/broadcasting stocks. Sirius XM is well within the wheelhouse of Buffett's investment areas of focus. Lastly, Sirius XM Holdings provides a value proposition that's incredibly difficult to find in a historically expensive stock market. While economic uncertainty has weighed on its cumulative subscriber count in recent quarters, Sirius XM's shares are currently valued at a little over 7 times forecast earnings per share in 2025. There's an attractive risk-versus-reward profile. However, Sirius XM isn't the only company which checks all the right boxes that exhibited a price dislocation in recent months. Brand-name power tools and outdoor products company Stanley Black & Decker (NYSE: SWK) is the other possible stock I believe Buffett was eyeing with $10 billion in hand. As of this writing on June 5, Stanley Black & Decker is a $10 billion company. Usually, acquisitions require the buyer to pay a premium to get the nod of approval from shareholders. But during the tariff-related stock market plunge in early April, Stanley Black & Decker stock fell to around an $8.5 billion market cap. It was well within range for a $10 billion buyout at this point -- especially with tariff-related cost and margin uncertainty hovering over the company. Although Berkshire Hathaway doesn't own any shares of Stanley Black & Decker, this isn't reason enough to believe it wasn't the alluded acquisition target. For starters, Buffett's investment philosophy focuses more on consumer behaviors than it does on innovation. Stanley Black & Decker owns a laundry list of brand-name tool and outdoor brands, including DeWalt, Craftsman, Irwin, Cub Cadet, Lenox, and its namesakes Stanley and Black & Decker. These brands are easily identifiable by consumers and have helped to build trust in the company for more than a century. Additionally, Stanley Black & Decker is time-tested. This is a company founded in 1843 that's grown organically and through acquisitions of its own. It's increased its base annual dividend in each of the last 58 years, and offers the second-longest streak among U.S. public companies of paying a dividend for 149 consecutive years. Companies don't pay a dividend annually for nearly 150 years by accident. This is a testament that its operating model works. Despite tariff-related uncertainty clouding the company's near-term outlook, management has taken steps to improve margins over the long run. Its global cost reduction program has resulted in roughly $1.7 billion in pre-tax annual run-rate cost savings since being introduced in mid-2022. Further, its supply chain remains nimble enough that shifting production to Mexico and the U.S. will help it avoid potential tariffs tied to China over the next two years. Most importantly, Stanley Black & Decker offers a historically tempting valuation discount. Accounting for all the headwinds it's currently working through, shares of Stanley Black & Decker are priced at roughly 11 times forecast earnings per share in 2026. For context, this represents a 37% discount to its average forward-year earnings multiple over the trailing-five-year period. If there was a $10 billion acquisition to be made by Warren Buffett's Berkshire Hathaway, either Sirius XM or Stanley Black & Decker perfectly fit the mold. Before you buy stock in Sirius XM, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Sirius XM wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $669,517!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $868,615!* Now, it's worth noting Stock Advisor's total average return is 792% — a market-crushing outperformance compared to 173% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Sean Williams has positions in Sirius XM. The Motley Fool has positions in and recommends Berkshire Hathaway. The Motley Fool has a disclosure policy. Warren Buffett Recently "Came Pretty Close" to Spending $10 Billion On an Acquisition, and I Strongly Believe One of These 2 Companies Was the Target was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
2 hours ago
- Business Wire
Brown-Forman Corporation (BF.A, BF.B) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Brown-Forman Corporation ('Brown-Forman' or the 'Company') (NYSE: BF.A, BF.B) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN BROWN-FORMAN (BF.A, BF.B), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmith@ by telephone at (215) 638-4847 or visit our website at What Happened? On June 5, 2025, Brown-Forman reported financial results for its fourth quarter and full year 2025. Amongst other things, the Company reported 'net sales decreased 7% to $894 million,' 'reported operating income decreased 45%,' and 'diluted earnings per share decreased 45%.' The Company stated that 'results did not meet our long-term growth aspirations.' The Company further stated that, in fiscal year 2026, it would 'expect continued headwinds' including declines in organic net sales and operating income, as the Company undergoes a 'significant evolution of [its] U.S. distribution.' On this news, Brown-Forman's stock price fell $5.95, or 17.92%, to close at $27.25 on June 5, 2025, thereby injuring investors. Contact Us To Participate or Learn More: If you purchased Brown-Forman securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us: Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, Telephone: (215) 638-4847 Email: howardsmith@ Visit our website at: This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
